異物混入、日本向けのみ　モデルナワクチン委託先

　【ニューヨーク時事】米モデルナ製の新型コロナウイルスワクチンで異物混入が確認された問題で、製造工程の一部を委託されたスペインの製薬会社が２６日、声明を発表し、混入が見つかったのは日本向けの特定の製造ロット番号のワクチンのみであると明らかにした。原因については調査中で、モデルナや日本での流通を担う武田薬品工業とともに、関係当局と協力して究明に当たっていると表明した。
　声明を出したのは、マドリードに本社がある製薬会社ロビ。モデルナによると、ロビは米国以外に供給するワクチンの瓶への充填（じゅうてん）などの最終工程を担当している。（2021/08/27-07:36）

Foreign materials were found only in vials of U.S. biotechnology company Moderna Inc.'s COVID-19 vaccine with one product lot number distributed exclusively in Japan, Spanish pharmaceutical company Rovi, which participates in the vaccine's manufacturing processes, said Thursday.
   The Madrid-based company also said in a statement that it is conducting an investigation to find the cause of the contamination, in cooperation with health authorities, as well as Moderna and Japan's Takeda Pharmaceutical Co. , which is in charge of the distribution of the Moderna vaccine in Japan.
   The statement was released after multiple vaccination centers in Japan reported that some unused vials of the Moderna vaccine contained foreign materials.
   According to Moderna, Rovi is responsible for the final manufacturing process, including vial filling, of the Moderna vaccine supplied to countries other than the United States.
   The Spanish firm said that the contamination may have occurred in one of its manufacturing lines and that the lot in question and two adjacent lots have been put on hold as a precaution.